首页 正文

Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies

{{output}}
Multiple sclerosis (MS) is an inflammatory and demyelinating disease of central nervous system comprising several subtypes. Pharmacological treatment involves only few drugs. Among these, interferon beta (IFN-β) and glatiramer acetate were the most used. Alth... ...